Stargardt disease-associated missense and synonymous ABCA4 variants result in aberrant splicing
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddad129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Melita Kaltak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, Radboud University Medical Center, Nijmegen, 6525 GA, The Netherlands. Hauptthemen laut MEDLINE: Macular Degeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marie Sklodowska-Curie Innovative Training Networks.
Abstract (Originalsprache)
Missense variants in ABCA4 constitute ~50% of causal variants in Stargardt disease (STGD1). Their pathogenicity is attributed to their direct effect on protein function, whilst their potential impact on pre-mRNA splicing disruption remains poorly understood. Interestingly, synonymous ABCA4 variants have previously been classified as ‘severe’ variants based on in silico analyses. Here, we systemically investigated the role of synonymous and missense variants in ABCA4 splicing by combining computational predictions and experimental assays. To identify variants of interest, we used SpliceAI to ascribe defective splice predictions on a dataset of 5579 biallelic STGD1 probands. We selected those variants with predicted delta scores for acceptor/donor gain > 0.20, and no previous reports on their effect on splicing. Fifteen ABCA4 variants were selected, 4 of which were predicted to create a new splice acceptor site and 11 to create a new splice donor site. In addition, three variants of interest with delta scores < 0.20 were included. The variants were introduced in wild-type midigenes that contained 4–12 kb of ABCA4 genomic sequence, which were subsequently expressed in HEK293T cells. By using RT-PCR and Sanger sequencing, we identified splice aberrations for 16 of 18 analyzed variants. SpliceAI correctly predicted the outcomes for 15 out of 18 variants, illustrating its reliability in predicting the impact of coding ABCA4 variants on splicing. Our findings highlight a causal role for coding ABCA4 variants in splicing aberrations, improving the severity assessment of missense and synonymous ABCA4 variants, and guiding to new treatment strategies for STGD1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, Radboud University Medical Center, Nijmegen, 6525 GA, The Netherlands.
- R&D Department, ProQR Therapeutics, Leiden, 2333 CK, The Netherlands.
ORCID-Profile: Melita Kaltak
Förderung
- Marie Sklodowska-Curie Innovative Training Networks
Zitieren
APA
Kaltak, M., Corradi, Z., Collin, R. W. J., Swildens, J., & Cremers, F. P. M. (2023). Stargardt disease-associated missense and synonymous ABCA4 variants result in aberrant splicing. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad129
Vancouver
Kaltak M, Corradi Z, Collin RWJ, Swildens J, Cremers FPM. Stargardt disease-associated missense and synonymous ABCA4 variants result in aberrant splicing. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad129
BibTeX
@article{Kaltak2023,
author = {Kaltak, Melita and Corradi, Zelia and Collin, Rob W J and Swildens, Jim and Cremers, Frans P M},
title = {Stargardt disease-associated missense and synonymous ABCA4 variants result in aberrant splicing},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddad129}
}
EUVIMED